Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature

JAMA: The Journal of the American Medical Association

Volumn 271, Issue 9, 1994, Pages 698-702

  Colditz, Graham A ^a   Brewer, Timothy F ^b   Berkey, Catherine S ^c   Wilson, Mary E ^d   Burdick, Elisabeth ^d   Fineberg, Harvey V ^e   Mosteller, Frederick ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d Alfred L Frechette Postdoctoral Research Fellowship in Public Health from the Massachusetts Health Research Institute Potts Foundation ^*  (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; MATHEMATICAL ANALYSIS; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; TUBERCULOSIS;

BCG VACCINE; HUMAN; MEDLINE; RESEARCH DESIGN; SUPPORT, U.S. GOV'T, P.H.S.; TUBERCULOSIS; UNITED STATES;

EID: 0028153628     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03510330076038     Document Type: Article

References (68)

1. Rieder HL, Cauthen GM, Comstock GW, Snider DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;11:79-98.
2. Centers for Disease Control and Prevention. Tuberculosis mortality—United States, 1992. MMWR Morb Mortal Wkly Rep. 1992;42:696-697,703-704.
3. Centers for Disease Control and Prevention. Prevention and control of tuberculosis in US communities with at-risk minority populations. MMWR Morb Mortal Wkly Rep. 1992;41(RR-5):1-11.
4. Hamburg MA. The challenge of controlling tuberculosis in New York City. N Y State J Med. 1992;92:291-293.
5. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JD, Cauthen GM, Dooley SM. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328:521-526.
6. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991; 40:585-591.
7. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521.
8. Fischl MA, Uttamchandani RB, Daikos GL, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992;117:177-183.
9. Pearson, ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant mycobacterium tuberculosis. Ann Intern Med. 1992;117: 191-196.
10. Centers for Disease Control and Prevention. National action plan to combat multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 1992; 41:5-8.
11. Centers for Disease Control. Use of BCG vaccines in the control of tuberculosis: a joint statement by the ACIP and the Advisory Committee for Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1988;37:663-664,669-675.
12. BCG: bad news from India. Lancet. 1980;1:73-74. Editorial.
13. BCG vaccination after the Madras study. Lancet. 1981;1309-1310. Editorial.
14. Smith PG. Case-control studies of the efficacy of BCG against tuberculosis. In: International Union Against Tuberculosis, ed. Proceedings of the 26th IUAT World Conference on Tuberculosis and Respiratory Diseases. Singapore, Japan: Professional Postgraduate Services International; 1987:73-79.
15. Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res. 1980;72(suppl):1-74.
16. ten Dam HG. Research on BCG vaccination. Adv Tuberc Res. 1984;21:79-106.
17. von Reyn CF, Clements CJ, Mann JM. Human immunodeficiency virus infection and routine childhood immunization. Lancet. 1987;2:669-672.
18. ten Dam HG, Toman K, Hitze KL, Guld J. Present knowledge of immunization against tuberculosis. Bull World Health Organ. 1976;54:255-269.
19. Comstock GW. Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis. 1988;138:479-480.
20. Fine PEM, Rodrigues LC. Modern vaccines: mycobacterial diseases. Lancet. 1990;335:1016-1020.
21. L'Abbe HA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987; 107:224-233.
22. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analysis of randomized controlled trials. N Engl J Med. 1987;316:450-455.
23. Aronson JD. Protective vaccination against tuberculosis with special reference to BCG vaccination. Am Rev Tuberc. 1948;58:255-281.
24. Heimbeck J. Tuberculosis in hospital nurses. Tubercle. 1936;18:97-99.
25. Rosenthal SR, Leppman M. Tuberculosis control: BCG vaccination in a tuberculosis control program in infants, children and adults. Trans Natl Tuberc Assoc. 1953;161-168.
26. Rosenthal SR. Standardization and efficacy of BCG vaccination against tuberculosis. JAMA. 1955; 157:801-807.
27. Ferguson RG. BCG vaccination in hospitals and sanatoria of Saskatchewan. Am Rev Tuberc. 1946; 54:325-339.
28. Rosenthal SR. The use of BCG vaccination among medical and nursing students. Hospitals. 1943;17:75-78.
29. Houghton HGH, Horne NW. BCG vaccination of nurses and students in Edinburgh. Lancet. 1950; 2:533-536.
30. DeFriez Al, Badger TL. Tuberculosis in BCG-vaccinated nurses. N Engl J Med. 1957;257:161-165.
31. Dickie HA. Tuberculosis in student nurses and medical students at the University of Wisconsin. Ann Intern Med. 1950;33:941-959.
32. Burrill D, Enarson DA, Allen EA, Grzyboski S. Tuberculosis in female nurses in British Columbia: implications for control programs. Can Med Assoc J. 1985;132:137-140.
33. Geiseler PJ, Nelson HE, Crispen RG, Moses VK. Tuberculosis in physicians: a continuing problem. Am Rev Respir Dis. 1986;133:773-778.
34. National Research Council. Combining Information: Statistical Issues and Opportunities for Research. Washington, DC: National Academy Press; 1992.
35. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7:177-188.
36. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. In: Colditz GA, Brewer T, Berkey CS, et al, eds. The Efficacy of BCG in the Prevention of Tuberculosis: Report to the CDC. Boston, Mass: Harvard University Press; June 1993.
37. Morris CN. Parametric empirical Bayes inference: theory and applications. J Am Stat Assoc. 1983;78:47-55.
38. Hennekens CH, Buring JE. Epidemiology in Medicine. 1st ed. Boston, Mass: Little Brown & Co Inc; 1987:79-82.
39. Coetzee AM, Berjak J. BCG in the prevention of tuberculosis in an adult population. Proc Mine Med Of Ficers Assoc. 1968;48:41-53.
40. Ferguson RG, Simes AB. BCG vaccination of Indian infants in Saskatchewan. Tubercle. 1949;30: 5-11.
41. Hart PD, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life: final report to the Medical Research Council. BMJ. 1977;2:293-295.
42. Rosenthal SR, Loewinsohn E, Graham ML, et al. BCG vaccination in tuberculous households. Am Rev Respir Dis. 1960;84:690-704.
43. Vandiviere HM, Dworski M, Melvin IG, Watson HA, Begley J. Efficacy of bacillus Calmette-Guerin and isoniazid-resistant bacillus Calmette-Guerin with and without isoniazid chemoprophylaxis from day of vaccination, II: field trial in man. Am Rev Respir Dis. 1973;108:301-313.
44. Stein SC, Aronson JD. The occurrence of pulmonary lesions in BCG-vaccinated and unvaccinated persons. Am Rev Tuberc. 1953;68:692-712.
45. Frimodt-Moller J, Acharyulu GS, Pillai KK. Observations on the protective effect of BCG vaccination in a south Indian rural population. Bull Int Union Tuberc. 1973;48:40-52.
46. Comstock GW, Woolpert SF, Livesay VT. Tuberculosis studies in Muscogee County, Georgia: twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep. 1976;91:276-280.
47. Comstock GW, Livesay VT, Woolpert SF. Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health. 1974;64:283-291.
48. Comstock GW, Webster RG. Tuberculosis studies in Muscogee County, Georgia, VII: a twenty-year evaluation of BCG vaccination in a school population. Am Rev Respir Dis. 1969;100:839-845.
49. Rosenthal SR, Loewinsohn E, Graham ML, et al. BCG vaccination against tuberculosis in Chicago: a twenty-year study statistically analyzed. Pediatrics. 1961;28:622-641.
50. Levine MI, Sackett MF. Results of BCG immunization in New York City. Am Rev Tuberc. 1948;53:517-532.
51. Aronson JD, Aronson CF, Taylor HC. A twenty-year appraisal of BCG vaccination in the control of tuberculosis. Arch Intern Med. 1958;101:881-893.
52. Houston S, Fanning A, Soskoine CL, Fraser N. The effectiveness of bacillus Calmette-Guerin (BCG) vaccination against tuberculosis. Am J Epidemiol. 1990;131:340-349.
53. Miceli I, De Kanto IN, Colaiacovo D, et al. Evaluation of the effectiveness of BCG vaccination using the case-control method in Buenos Aires, Argentina. Int J Epidemiol. 1988;17:629-634.
54. Myint TT, Win H, Aye HH, Kyaw-Myint TO. Case-control study on evaluation of BCG vaccination of newborns in Rangoon, Burma. Ann Trop Paediatr. 1987;7:159-166.
55. Packe GE, Innes JA. Protective effect of BCG vaccination in infant Asians: a case-control study. Arch Dis Child. 1988;63:277-281.
56. Putrali J, Sutrisna B, Rahayoe N, Gunardi AS. A case-control study of effectiveness of vaccination in children in Jakarta, Indonesia. In: Proceedings of the Eastern Regional Tuberculosis Conference of IUAT, 1983. Jakarta, Indonesia; November 20-25, 1983:194-200.
57. Rodrigues LC, Gill ON, Smith PG. BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England. Int J Epidemiol Community Health. 1991;45:78-80.
58. Sirinavin S, Chotpitayasunondh T, Suwanjutha S, Sunalorn P, Chantarojanasiri T. Protective efficacy of neonatal bacillus Calmette-Guerin vaccination against tuberculosis. Pediatr Infect Dis J. 1991;10:350-365.
59. Young TK, Hershfield ES. A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. Am J Public Health. 1986;76:783-786.
60. Patel A, Schofield F, Siskind V, Abrahams E, Parker J. Case-control evaluation of a school-age BCG vaccination programme in subtropical Australia. Bull World Health Organ. 1991;69:425-433.
61. Shapiro C, Cook N, Evans D, et al. A case-control study of BCG and childhood tuberculosis in Cali, Colombia. Int J Epidemiol. 1985;14:441-446.
62. Camargos PAM, Guimaraes MDC, Antunes CMF. Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: a case-control study. Int J Epidemiol. 1988; 17:193-197.
63. Wunsch-Filho V, Moncau JE, Nakao N. Methodological considerations in case control studies to evaluate BCG vaccine effectiveness. Int J Epidemiol. 1993;22:149-155.
64. Springett VH, Sutherland I. Comparison of the efficacy of liquid and freeze-dried strains of BCG vaccine in preventing tuberculosis. BMJ. 1970;4: 148-150.
65. Tuberculosis Prevention Trial. Trial of BCG vaccines in south India for tuberculosis prevention: first report. Bull World Health Organ. 1979;57:819-827.
66. Clemens JD, Chuong JH, Feinstein AR. The BCG controversy: a methodological and statistical reappraisal. JAMA. 1983;249:2362-2369.
67. ten Dam HG. BCG vaccination. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. New York, NY: Marcel Dekker Inc; 1993:251-274.
68. Halvorsen KT, Burdick E, Colditz GA, Frazier HS, Mosteller F. Combining results from independent investigations: meta-analysis in clinical research. In: Bailar JC, Mosteller F, eds. Medical Uses of Statistics. 2nd ed. Boston, Mass: New England Journal of Medicine Books; 1992:413-426.